Page last updated: 2024-11-07

pilocarpine and Acquired Immunodeficiency Syndrome

pilocarpine has been researched along with Acquired Immunodeficiency Syndrome in 1 studies

Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.

Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
THEODORE, FH1

Other Studies

1 other study available for pilocarpine and Acquired Immunodeficiency Syndrome

ArticleYear
THE USE OF TENSION-LOWERING DRUGS AND OTHER AIDS IN THE MANAGEMENT OF RECURRENT CORNEAL EROSIONS.
    Eye, ear, nose & throat monthly, 1964, Volume: 43

    Topics: Acetazolamide; Acquired Immunodeficiency Syndrome; Codeine; Conjunctivitis; Cornea; Corneal Diseases

1964